[HTML][HTML] Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …
management of critically ill patients and beta-lactams are the most common antibiotic class …
Interaction of obesity and infections
NV Dhurandhar, D Bailey, D Thomas - Obesity reviews, 2015 - Wiley Online Library
There is evidence that certain infections may induce obesity. Obese persons may also have
more severe infections and have compromised response to therapies. The objective of this …
more severe infections and have compromised response to therapies. The objective of this …
Ten-day vonoprazan-amoxicillin dual therapy as a first-line treatment of Helicobacter pylori infection compared with bismuth-containing quadruple therapy
HS Qian, WJ Li, YN Dang, LR Li, XB Xu… - Official journal of the …, 2023 - journals.lww.com
METHODS: A total of 375 treatment-naive, H. pylori-infected subjects were randomly
assigned in a 1: 1: 1 ratio into 3 regimen groups including VHA-dual (vonoprazan 20 mg …
assigned in a 1: 1: 1 ratio into 3 regimen groups including VHA-dual (vonoprazan 20 mg …
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …
the percentage of the dosing interval (% T) during which their free serum concentration …
Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review
AS Alobaid, M Hites, J Lipman, FS Taccone… - International journal of …, 2016 - Elsevier
The increased prevalence of obesity presents challenges for clinicians aiming to provide
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …
Population pharmacokinetics of piperacillin in nonobese, obese, and morbidly obese critically ill patients
The treatment of infections in critically ill obese and morbidly obese patients is challenging
because of the combined physiological changes that result from obesity and critical illness …
because of the combined physiological changes that result from obesity and critical illness …
Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy
Background As a first‐line therapy for Helicobacter pylori, dual therapy with vonoprazan and
amoxicillin (VA‐dual) provides an eradication rate similar to that of vonoprazan‐based triple …
amoxicillin (VA‐dual) provides an eradication rate similar to that of vonoprazan‐based triple …
Pharmacokinetics and pharmacodynamics in antibiotic dose optimization
SKB Sy, L Zhuang, H Derendorf - Expert opinion on drug …, 2016 - Taylor & Francis
Introduction: Identifying the optimized dosing regimen and algorithm is critical in the
development of antibiotics. Suboptimal regimens and inappropriate choice of drug give rise …
development of antibiotics. Suboptimal regimens and inappropriate choice of drug give rise …
[HTML][HTML] Pharmacokinetic/pharmacodynamic considerations of beta-lactam antibiotics in adult critically ill patients
AM Masich, MS Heavner, JP Gonzales… - … infectious disease reports, 2018 - Springer
Abstract Purpose of Review Beta-lactam antibiotics are commonly prescribed in critically ill
patients for a variety of infectious conditions. Our understanding of how critical illness alters …
patients for a variety of infectious conditions. Our understanding of how critical illness alters …
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients
EK Chung, SC Cheatham, MR Fleming… - The Journal of …, 2015 - Wiley Online Library
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in …
pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in …